Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Immunol. 2017 Dec 18;200(3):1159–1168. doi: 10.4049/jimmunol.1700965

Figure 6. P2X7, P2Y11 and P2Y13 receptor do not regulate ATP-induced protein secretion of CXCL5 at 48h in human MDM.

Figure 6

Effect of: A) selective P2X7 receptor antagonist (5 μM A438079; N=3 donors), B) selective P2Y11 receptor antagonist (10 μM NF340; N=4 donors), and C) selective P2Y13 receptor antagonist (10 μM MRS2211; N=6 donors) on ATP-induced CXCL5 secretion. D) Effect of co-application of both P2Y11 (NF340) and P2Y13 (MRS2211) antagonists on ATP-induced CXCL5 secretion (N=3 donors).